Cytophage Technologies (TSXV:CYTO) Net Interest Income : C$0.26 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Cytophage Technologies's net interest income for the three months ended in Mar. 2024 was C$0.02 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2024 was C$0.26 Mil.

Cytophage Technologies Net Interest Income Historical Data

The historical data trend for Cytophage Technologies's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Net Interest Income Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Net Interest Income

-0.03

0.09

0.24

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Net Interest Income	Get a 7-Day Free Trial			0.10	-	-	0.25	0.02

Cytophage Technologies Net Interest Income Calculation

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.26 Mil.

Cytophage Technologies Net Interest Income Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Net Interest Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.